Revenue (Tables)

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Biologics	41 %	28 %	40 %	28 %
Generics	16 %	21 %	17 %	20 %
Pharma	24 %	27 %	24 %	28 %
Contract-Manufactured Products	19 %	24 %	19 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
High-Value Product Components	55 %	44 %	54 %	44 %
High-Value Product Delivery Devices	4 %	6 %	4 %	5 %
Standard Packaging	22 %	26 %	23 %	27 %
Contract-Manufactured Products	19 %	24 %	19 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Americas	43 %	50 %	45 %	49 %
Europe, Middle East, Africa	47 %	42 %	45 %	43 %
Asia Pacific	10 %	8 %	10 %	8 %
	100 %	100 %	100 %	100 %

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2020	$	10.9
Contract assets, June 30, 2021	10.1
Change in contract assets - increase (decrease)	$	(0.8)
Deferred income, December 31, 2020	$	(57.1)
Deferred income, June 30, 2021	(40.0)
Change in deferred income - decrease (increase)	$	17.1